Joris Bakker
Associate
Get their honest, personalized take on your startup.
Sign in to pitch Joris →At a glance
- Full Name
- Joris Bakker
- Firm
- H2 Equity Partners
- Firm Type
- Private equity investment firm
- Check Size
- Equity investments up to £75 million
- Target Company Profile
- Mid-sized, profitable B2B companies with reasonable growth; family-owned or owner-managed businesses, succession or retirement sales, and corporate carve-outs
- Sector Focus
- Business-to-business companies; H2’s portfolio spans healthcare/medical devices, transport services, chemicals, recruitment, manufacturing, offshore equipment, traffic management, and related services
- Geographic Focus
- UK and Ireland; H2’s current site also describes its historical Western European/Benelux focus
- Location
- Amsterdam, Netherlands
Background
The stub identifies Joris Bakker as an Associate connected to H2 Equity Partners, but I could not independently verify a public profile page, biography, LinkedIn profile, headshot, or deal attribution for him. H2’s archived 2014 website listed its Netherlands office at Oosteinde 19, 1017 WT Amsterdam, with the phone number +31 (0) 20 679 08 22 and email [hidden]; that archived team page did not list Joris Bakker among the 20 professionals shown at that time.
H2 Equity Partners is a Western European private equity investment firm founded in 1991. Its current website states that it has over 30 years of hands-on investing experience and over £500 million of committed funding, investing in mid-sized companies that can benefit from operational support.
The firm’s current strategy is not seed or angel investing. H2 describes its targets as mid-sized, profitable B2B companies headquartered in the UK and Ireland, typically with £20-250 million of revenue, and says it can make equity investments up to £75 million.
Investment Thesis & Focus
- H2 invests in “mid-sized companies in the UK, Ireland and the Benelux with significant growth or improvement potential that can benefit from our hands-on support.”
- The firm looks for buy-and-build opportunities where it can become the largest single shareholder and partner with management teams to support a growth plan.
- Typical target situations include family-owned and owner-managed companies, succession and retirement sales, and corporate carve-outs.
- Typical companies are profitable, B2B-focused, and in sectors with reasonable growth.
- H2 emphasizes hands-on operating support: “We partner with management teams to implement ambitious plans faster and better.”
- I found no verified public investment thesis specifically attributable to Joris Bakker.
Notable Investments
- KB Event - Specialist entertainment logistics provider serving live events, music, theatre, and exhibitions; H2 invested in April 2026.
- Safety Shield Global - AI safety solutions company; H2 announced its investment on February 3, 2026.
- William Blythe - Chemicals business carved out from Synthomer plc; H2 announced the carve-out on May 6, 2025.
- Coach Travel Group - Transport services platform; H2 announced its investment on June 12, 2024.
- Buttress Group - Warewashing supply and maintenance business; H2 announced its investment alongside management on January 26, 2024.
- Medical Imaging Systems / MIS Healthcare - Diagnostic imaging and medical devices company; H2 announced its investment on January 10, 2024.
- GBUK Group - Healthcare medical devices company; H2 announced divestment to A&M Capital Europe LLP on January 10, 2024.
- Acal BFi - Technology and electronics distribution business; H2 announced successful divestment on June 2, 2026.
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.